Work

Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer

Year: 2025
Type: article
Abstract: demonstrate precision therapeutic potential with robust efficacy and safety, offering a novel approach for targeted therapy in PCa.
Language: English
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W4417068324
FWCI: 1.044
Cites:
Cited by: 4
Related to: